cdmo.directory
← Compare landing

Dipharma vs ESTEVE CDMO

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryDipharmaESTEVE CDMO
SummaryGlobal CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.ESTEVE CDMO is adding manufacturing capacity in the USA and China, including a $33 million expansion at its Morton Grove, Illinois site. Its China investment adds three manufacturing workshops with 250 m³ of total reaction volume, and its US assets add early development capabilities.
Services
  • API Synthesis & Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
Data not yet provided.
Modalities
  • Small Molecule
Data not yet provided.
Development capabilities
  • Analytical method development
Data not yet provided.
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
Data not yet provided.
Locations
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
  • Morton Grove, Morton Grove, Illinois, USA
  • China manufacturing site, China
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Dipharma alternatives · ESTEVE CDMO alternatives

Markdown mirror: /compare/dipharma/esteve-cdmo.md